Broadline

Country: European Union

Language: Slovenian

Source: EMA (European Medicines Agency)

Buy It Now

Active ingredient:

eprinomektin, fipronil, prazikvantel, (S) -metopren

Available from:

Boehringer Ingelheim Vetmedica GmbH

ATC code:

QP54AA54

INN (International Name):

eprinomectin, fipronil, praziquantel, (S)-methoprene

Therapeutic group:

Mačke

Therapeutic area:

Antiparasitic products, insecticides and repellents, Avermectins, Eprinomectin, combinations,

Therapeutic indications:

Za mačke z ali brez nevarnosti mešanih napadov cestod, nematod in ektoparazitov. Zdravilo je izključno navedeno ko so vse tri skupine, ki so usmerjeni na istem času. EctoparasitesTreatment in preprečevanje infestations za bolhe (Ctenocephalides felis). Odprava bolhe v 24 urah. Eno zdravljenje, preprečuje nadaljnje infestations za vsaj en mesec. Preprečevanje okoljskih bolh onesnaženja s zavira razvoj bolh nezreli fazi (jajca, ličinke in pupae) za več kot en mesec. Izdelek se lahko uporablja kot del strategije zdravljenja za nadzor alergijskega dermatitisa bolha (FAD). Zdravljenje in preprečevanje infestations s klopi (Ixodes ricinus). Odstranitev klopov v roku 48 ur. Eno zdravljenje, preprečuje nadaljnje infestations za do 3 tednov. Zdravljenje notoedric mange (Notoedres cati). CestodesTreatment od infestations z tapeworms (Dipylidium caninum, Taenia taeniaeformis, Echinococcus multilocularis, Joyeuxiella pasqualei (za odrasle), in Joyeuxiella fuhrmanni (za odrasle)). NematodesTreatment od infestations z prebavil nematodes (L3, L4 ličinke in odrasle od Toxocara cati, odraslimi Toxascaris leonina, L4 ličinke in odrasle od Ancylostoma tubaeforme in Ancylostoma ceylanicum, in odraslimi Ancylostoma brazilienze). Zdravljenje infestations z mačji lungworms (L3 ličinke, L4 ličinke in odrasle od Aelurostrongylus abstrusus, L4 ličinke in odrasle od Troglostrongylus brevior). Zdravljenje infestations z vesical črvi (Capillaria plica). Preprečevanje heartworm bolezni (Dirofilaria immitis ličinke) za en mesec.

Product summary:

Revision: 10

Authorization status:

Pooblaščeni

Authorization date:

2013-12-04

Patient Information leaflet

                                18
B. NAVODILO ZA UPORABO
19
NAVODILO ZA UPORABO
BROADLINE KOŽNI NANOS, RAZTOPINA ZA MAČKE < 2,5 KG
BROADLINE KOŽNI NANOS, RAZTOPINA ZA MAČKE 2,5-7,5 KG
1.
IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM TER
PROIZVAJALEC ZDRAVILA, ODGOVOREN ZA SPROŠČANJE SERIJ, ČE STA
RAZLIČNA
Imetnik dovoljenja za promet z zdravilom:
Boehringer Ingelheim Vetmedica GmbH
55216 Ingelheim/Rhein
NEMČIJA
Proizvajalec, odgovoren za sproščanje serij:
Boehringer Ingelheim Animal Health France SCS
4 Chemin du Calquet,
31000 Toulouse
Francija
2.
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI
BROADLINE kožni nanos, raztopina za mačke < 2,5 kg
BROADLINE kožni nanos, raztopina za mačke 2,5-7,5 kg
3.
NAVEDBA UČINKOVIN(E) IN DRUGIH SESTAVIN
Enkratni odmerek (aplikator) vsebuje:
Volumen
odmerka (ml)
fipronil
(mg)
(S)-metopren
(mg)
eprinomektin
(mg)
prazikvantel
(mg)
Mačke < 2,5 kg
0,3
24,9
30,0
1,20
24,9
Mačke 2,5-7,5 kg
0,9
74,7
90,0
3,60
74,7
Pomožne snovi: butilhidroksitoluen (E321) 1 mg/ml.
Kožni nanos, raztopina.
4.
INDIKACIJE
Za mačke z obstoječo mešano infestacijo, ali z izpostavljenostjo
mešani infestaciji s cestodi, nematodi
in ektoparaziti. Zdravilo je indicirano izključno za zdravljenje vseh
treh skupin parazitov hkrati.
Ektoparaziti
-
Zdravljenje in preprečevanje bolhavosti (
_Ctenocephalides felis_
). Odpravi bolhe v 24 urah. Eno
zdravljenje vsaj 1 mesec preprečuje ponovne infestacije z bolhami.
Preprečevanje kontaminacije
okolice z bolhami z zaviranjem razvoja nezrelih razvojnih oblik bolh
(jajčec, ličink in bub) več
kot 1 mesec.
-
Zdravilo je del zdravljenja in preprečevanja alergijskih
dermatitisov, ki jih povzroča bolhavost
(FAD).
-
Zdravljenje in preprečevanje klopavosti (
_Ixodes_
_ricinus)_
. Odpravi klope v 48 urah. Eno
zdravljenje do 3 tedne preprečuje ponovne infestacije s klopi.
-
Zdravljenje garjavosti (
_Notoedres cati_
)
_._
20
Cestodi
-
Zdravljenje infestacij s trakuljami (
_Dipylidium caninum, Taenia taeniaeformis, Echinococcus _
_multilocularis, Joyeuxiella pasqualei _
(od
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                1
PRILOGA I
POVZETEK GLAVNIH ZNAČILNOSTI ZDRAVILA
2
1.
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI
BROADLINE kožni nanos, raztopina za mačke < 2,5 kg
BROADLINE kožni nanos, raztopina za mačke 2,5-7,5 kg
2.
KAKOVOSTNA IN KOLIČINSKA SESTAVA
UČINKOVINE:
Enkratni odmerek vsebuje:
Volumen
odmerka (ml)
fipronil
(mg)
(S)-metopren
(mg)
eprinomektin
(mg)
prazikvantel
(mg)
Mačke < 2,5 kg
0,3
24,9
30,0
1,20
24,9
Mačke 2,5 – 7,5 kg
0,9
74,7
90,0
3,60
74,7
POMOŽNA SNOV:
butilhidroksitoluen (E321) 1 mg/ml.
Za celoten seznam pomožnih snovi, glejte poglavje 6.1.
3.
FARMACEVTSKA OBLIKA
Kožni nanos, raztopina.
Bistra brezbarvna do rumena, rdeče/rjava raztopina.
4.
KLINIČNI PODATKI
4.1
CILJNE ŽIVALSKE VRSTE
Mačke.
4.2
INDIKACIJE ZA UPORABO PRI CILJNIH ŽIVALSKIH VRSTAH
Za mačke z obstoječo mešano infestacijo, ali mačke ki so
izpostavljene mešani infestaciji s cestodi,
nematodi in ektoparaziti. Zdravilo za uporabo v veterinarski medicini
je indicirano izključno za
zdravljenje vseh treh skupin parazitov hkrati.
Ektoparaziti
-
Zdravljenje in preprečevanje bolhavosti (
_Ctenocephalides felis_
). Odpravi bolhe v 24 urah. Eno
zdravljenje vsaj 1 mesec preprečuje ponovne infestacije z bolhami.
-
Preprečevanje kontaminacije okolice z bolhami z zaviranjem razvoja
nezrelih razvojnih oblik
bolh (jajčec, ličink in bub) več kot 1 mesec.
-
Zdravilo je del zdravljenja in preprečevanja alergijskih
dermatitisov, ki jih povzroča bolhavost
(FAD).
-
Zdravljenje in preprečevanje klopavosti (
_Ixodes_
_ricinus)_
. Odpravi klope v 48 urah. Eno
zdravljenje do 3 tedne preprečuje ponovne infestacije s klopi.
-
Zdravljenje garjavosti (
_Notoedres cati_
)
_._
Cestodi
-
Zdravljenje infestacij s trakuljami (
_Dipylidium caninum, Taenia taeniaeformis, Echinococcus _
_multilocularis, Joyeuxiella pasqualei _
(odrasli) in
_ Joyeuxiella fuhrmanni (_
odrasli
_))_
.
3
Nematodi
-
Zdravljenje infestacij z gastrointestinalnimi nematodi (L3, L4
ličinke in odrasli paraziti
_Toxocara cati_
, odrasle oblike
_Toxascaris leonina_
, L4 lič
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 08-04-2020
Summary of Product characteristics Summary of Product characteristics Bulgarian 08-04-2020
Public Assessment Report Public Assessment Report Bulgarian 17-10-2019
Patient Information leaflet Patient Information leaflet Spanish 08-04-2020
Public Assessment Report Public Assessment Report Spanish 17-10-2019
Patient Information leaflet Patient Information leaflet Czech 08-04-2020
Public Assessment Report Public Assessment Report Czech 17-10-2019
Patient Information leaflet Patient Information leaflet Danish 08-04-2020
Public Assessment Report Public Assessment Report Danish 17-10-2019
Patient Information leaflet Patient Information leaflet German 08-04-2020
Public Assessment Report Public Assessment Report German 17-10-2019
Patient Information leaflet Patient Information leaflet Estonian 08-04-2020
Public Assessment Report Public Assessment Report Estonian 17-10-2019
Patient Information leaflet Patient Information leaflet Greek 08-04-2020
Public Assessment Report Public Assessment Report Greek 17-10-2019
Patient Information leaflet Patient Information leaflet English 08-04-2020
Public Assessment Report Public Assessment Report English 17-10-2019
Patient Information leaflet Patient Information leaflet French 08-04-2020
Public Assessment Report Public Assessment Report French 17-10-2019
Patient Information leaflet Patient Information leaflet Italian 08-04-2020
Public Assessment Report Public Assessment Report Italian 17-10-2019
Patient Information leaflet Patient Information leaflet Latvian 08-04-2020
Public Assessment Report Public Assessment Report Latvian 17-10-2019
Patient Information leaflet Patient Information leaflet Lithuanian 08-04-2020
Summary of Product characteristics Summary of Product characteristics Lithuanian 08-04-2020
Public Assessment Report Public Assessment Report Lithuanian 17-10-2019
Patient Information leaflet Patient Information leaflet Hungarian 08-04-2020
Summary of Product characteristics Summary of Product characteristics Hungarian 08-04-2020
Public Assessment Report Public Assessment Report Hungarian 17-10-2019
Patient Information leaflet Patient Information leaflet Maltese 08-04-2020
Public Assessment Report Public Assessment Report Maltese 17-10-2019
Patient Information leaflet Patient Information leaflet Dutch 08-04-2020
Public Assessment Report Public Assessment Report Dutch 17-10-2019
Patient Information leaflet Patient Information leaflet Polish 08-04-2020
Public Assessment Report Public Assessment Report Polish 17-10-2019
Patient Information leaflet Patient Information leaflet Portuguese 08-04-2020
Summary of Product characteristics Summary of Product characteristics Portuguese 08-04-2020
Public Assessment Report Public Assessment Report Portuguese 17-10-2019
Patient Information leaflet Patient Information leaflet Romanian 08-04-2020
Public Assessment Report Public Assessment Report Romanian 17-10-2019
Patient Information leaflet Patient Information leaflet Slovak 08-04-2020
Public Assessment Report Public Assessment Report Slovak 17-10-2019
Patient Information leaflet Patient Information leaflet Finnish 08-04-2020
Public Assessment Report Public Assessment Report Finnish 17-10-2019
Patient Information leaflet Patient Information leaflet Swedish 08-04-2020
Public Assessment Report Public Assessment Report Swedish 17-10-2019
Patient Information leaflet Patient Information leaflet Norwegian 08-04-2020
Summary of Product characteristics Summary of Product characteristics Norwegian 08-04-2020
Patient Information leaflet Patient Information leaflet Icelandic 08-04-2020
Summary of Product characteristics Summary of Product characteristics Icelandic 08-04-2020
Patient Information leaflet Patient Information leaflet Croatian 08-04-2020
Public Assessment Report Public Assessment Report Croatian 17-10-2019

View documents history